"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to GLTO. [ FAQ on what and how to ask] For non-GLTO questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. Hans T. Schambye M.D., Ph.D.
Headquarter: Ole Maaloes Vej 3, Copenhagen N, Copenhagen, Denmark, 2200
Industry: Biotechnology, Employees: 5
Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
My Watchlist
